Patients with Deleterious Germline Variants in <i>STXBP2</i> Develop Toxicity after CAR-T Cell Therapy with Axicabtagene CiloleucelMark B. Leick, Marcela V. Maus, Grace Martin et al.|Blood|2022Cited by 3
Genomic correlates of clinical CAR T cell activityMark B. Leick, Marcela V. Maus, Filippo Birocchi et al.|Science Immunology|2026Cited by 0